ReSTOR IOL good in post LASIK cataract patients

Article

The use of the ReSTOR intraocular lens (IOL) (Alcon) for patients requiring cataract surgery after prior laser photoablation can result in excellent outcomes if optical results fall near emmetropia, according to Samuel Masket of the USA.

The use of the ReSTOR intraocular lens (IOL) (Alcon) for patients requiring cataract surgery after prior laser photoablation can result in excellent outcomes if optical results fall near emmetropia, according to Samuel Masket of the USA.

A total of 16 eyes of 11 patients were chosen to receive the lens after discussing thoroughly the risks, benefits and alternative lens options. Presurgical biometry was performed by partial coherence interferometry and appropriate formulae applied for IOL power calculation.

Surgery was performed using topical and intracameral anaesthesia employing phacoemulsification through clear corneal temporal incisions. Five patients underwent bilateral surgery while the remaining six required surgery in just one eye.

The results showed that all five bilateral patients were fully independent of spectacles after surgery and that, in all, ten of the eleven patients were very satisfied with the visual outcomes. One patient was moderately dissatisfied despite achieving 20/25 and J2+ uncorrected visual acuities. There were no complications of surgery and no IOLs were removed or exchanged.

Masket concluded that the ReSTOR IOL offers a good option for patients needing cataract surgery after laser photoablation.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.